Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Current Assets (2022 - 2025)

Historic Current Assets for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $6.3 million.

  • 60 Degrees Pharmaceuticals' Current Assets fell 844.26% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 844.26%. This contributed to the annual value of $5.4 million for FY2024, which is 2563.05% down from last year.
  • According to the latest figures from Q3 2025, 60 Degrees Pharmaceuticals' Current Assets is $6.3 million, which was down 844.26% from $3.8 million recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Current Assets' 5-year high stood at $8.9 million during Q3 2023, with a 5-year trough of $1.1 million in Q4 2022.
  • Moreover, its 4-year median value for Current Assets was $5.7 million (2023), whereas its average is $5.7 million.
  • Its Current Assets has fluctuated over the past 5 years, first surged by 55901.38% in 2023, then crashed by 3368.56% in 2024.
  • Over the past 4 years, 60 Degrees Pharmaceuticals' Current Assets (Quarter) stood at $1.1 million in 2022, then skyrocketed by 559.01% to $7.2 million in 2023, then fell by 25.63% to $5.4 million in 2024, then grew by 17.13% to $6.3 million in 2025.
  • Its Current Assets stands at $6.3 million for Q3 2025, versus $3.8 million for Q2 2025 and $5.7 million for Q1 2025.